Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate plus gefitinib for tubal ectopic pregnancy
ISRCTN67795930Phase 3Completed
- Sponsor
- University of Edinburgh and NHS Lothian ACCORD
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Ectopic pregnancy (EP) comparing Methotrexate + gefitinib with Methotrexate + placebo (2 arms). Primary endpoint: Surgical intervention for index ectopic pregnancy. Started Nov 2016; status: completed.
02
Drugs
gefitinibmethotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on ISRCTN67795930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN67795930.